Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 09, 2019

SELL
$45.92 - $67.67 $2,709 - $3,992
-59 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$42.73 - $76.53 $2,521 - $4,515
59 New
59 $2,000
Q3 2018

Oct 09, 2018

SELL
$71.67 - $91.95 $6,665 - $8,551
-93 Closed
0 $0
Q4 2017

Feb 16, 2018

BUY
$52.12 - $72.33 $4,847 - $6,726
93
93 $5,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.04B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.